Skip to Content
COVID-19 Response and Update
  • Login
  • Investors
    • Investors
    • Financial Reports
      • SEC Filings
      • Annual Reports
      • Quarterly & Other Reports
    • Events & Presentations
    • Stock Information
    • Corporate Governance
      • Policies
      • Executive Officers & Directors
      • Board Committees
    • Investor Resources
      • Analysts
      • Investor FAQ
      • Email Alerts
      • Information Request
      • RSS Feeds
  • Careers
  • News
  • Contact
  • USA Flag Corporate
  • India Flag India
Amneal
  • USA Flag Corporate
  • India Flag India
  • About Us
        • Leadership
        • Global Presence
          • United States
          • India
          • Ireland
        • Responsibility
        • A founder-led culture of redefining what's possible

  • Innovating Access
        • Timeline
        • Pipeline
        • Support
        • Driven by a passion to help more and more people be healthy

  • Essential Medicines
        • Biosciences
        • Specialty
        • Generics
        • Drug Safety
        • Quality
        • Addressing increasingly complex health and systemic needs

Our Commitment to the Parkinson’s Community

April 25, 2025

Every six minutes marks a new Parkinson’s disease diagnosis in the U.S.* Our commitment to the Parkinson’s community isn’t just focused on treatments; it’s about supporting patients in their journey to reclaim their identity and connections lost to Parkinson’s.

We also aim to foster hope, broaden understanding, and nurture a supportive community that includes healthcare professionals, advocacy groups, individuals living with Parkinson’s, and their caregivers and families. 

This Parkinson’s Awareness Month (April), we’re taking meaningful actions to support this resilient community: 

  • We donated a total of $1.5 million to multiple patient assistance foundations that support individuals living with Parkinson’s disease. 
  • We hosted a Lunch & Learn for our U.S. employees with Dr. Torres-Yaghi, MD, and Dr. Pagan, MD, two respected Movement Disorder Specialists from MedStar Georgetown University Hospital who shared valuable insights into Parkinson’s disease. They were joined by Anna Grill, the founder of Young Onset Parkinson’s Network (YOPN) who lives with PD, who shared insight into her treatment journey.
  • Recognized Spark the Night; an initiative to shed light on the often-hidden challenges faced by individuals living with Parkinson’s disease—especially at night, when feelings of isolation, anxiety, and loneliness can feel most overwhelming. 
  • Members of our Specialty field team visited our Brookhaven, NY Facility to see the manufacturing of one of our Parkinson’s products. 

We aim to empower, educate, and bring hope to the community. To learn more about resources check out our Thrive Newsletter here (Opens in a new tab). 

*Parkinson’s Foundation. (2023, March 28) parkinson.org/about-us/news/take6forpd-campaign (Opens in a new tab).

See How We Touch People's Lives
Amneal
  • About Us
    • Leadership
    • Global presence
      • United States
      • India
      • Ireland
    • Responsibility
  • Innovating Access
    • Timeline
    • Pipeline
    • Support
  • Essential Medicines
    • Biosciences
    • Specialty
    • Generics
    • Drug Safety
    • Quality
  • Menu Item
    • Linkedin
    • X
    • Facebook
    • Youtube
© 2026 Amneal Pharmaceuticals LLC. All rights reserved.
  • Expanded Access Policy
  • Terms & Conditions
  • Privacy Notice
  • Web Accessibility
  • NABP DDA
  • Sitemap
  • USA Flag Corporate
  • India Flag India